Intermittent cyclic tiludronate in the treatment of osteoporosis

Journal article

Peer reviewed

J. Y Reginster, C Christiansen, C Roux, J Fechtenbaum, A Rouillon and K. P Tou

Osteoporosis international, Vol.12(3), pp.169-177

01/03/2001

PMID: 11315234

Abstract

Biological and medical sciences

Bones, joints and connective tissue. Antiinflammatory agents

Medical sciences

Pharmacology. Drug treatments

1 Record Views

Title: Intermittent cyclic tiludronate in the treatment of osteoporosis
Creators - without role: J. Y Reginster - WHO Collaborating Center for Public Health Aspects of Osteoarticular Disorders, Department of Epidemiology and Public Health, Liège, Belgium
C Christiansen - Center for Clinical & Basic Research
C Roux - Hôpital Cochin
J Fechtenbaum - Hôpital Cochin
A Rouillon - Sanofi
K. P Tou - SANOFI Research Division, Malvern PA, United States
Publication Details: Osteoporosis international, Vol.12(3), pp.169-177
Publisher: Springer
Identifiers: 9952774708331
Academic Unit: King Saud University
Language: English
Resource Type: Journal article